NASDAQ: RYZB - RayzeBio, Inc. Common Stock

Yield per half year: 0%
Sector: Healthcare

RayzeBio, Inc. Common Stock

Underestimation
Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
P/E
0/10
0 48.77 -100% 0 0%
P/S 0 33.76 -100%
P/BV 0 4.82 -100%
P/FCF 0 60.98 -100%
Ev/Ebitda 0 -22.12 -100%
Ev/S 0 22.56 -100%
Ev/FCF 0 68.75 -100%
E/P 0 0.0178 -100%
Efficiency
Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Ebitda margin
0/10
0 4.83 -100% 0 0%
ROE 0 9.61 -100%
ROA 0 0.3359 -100%
ROIC 0 7.63 -100%
ROS 0 -25.17 -100%
ROCE 0 15.33 -100%
Debt
Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Debt/Ebitda
10/10
0 -3.67 -100% -0.0992 -100%
Nеt Debt/Ebitda 0 -3.44 -100%
Debt/Ratio 0 0.1972 -100%
Debt/Equity 0 1.65 -100%
Debt/Net Income 0 10.31 -100%
Dividends
Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Dividend yield
0/10
0 0.5496 -100% 0 0%
Number of years of dividend growth 0 0.1053 -100%
DSI 0 0.2174 -100%
Average dividend growth 0 0.0654 -100%
Average percentage for 5 years 0 0.4928 -100%
Average percentage for payments 0 43.56 -100%
Difference from average difference in sector -0.5496
Growth impulse
Parameter Grade Value Sector average Difference with sector, %
Growth impulse Revenue 5 years
0/10
0 -56.89 -100%
Growth impulse Ebitda 5 years 953.57 -64.81 -1571.33%
Growth impulse Net Income 5 years 820.35 -58.33 -1506.39%
Growth impulse FCF 5 years 3138.04 -47 -6776.68%
Growth impulse EPS 5 years 2126.11 -32.41 -6660.04%
IP Score
4.1/10

Similar companies

Amgen

Alexion

ABIOMED

Gilead Sciences